Biotech stocks are seeing significant premarket moves on Monday, suggesting potential trading opportunities.
By evaluating sentiment and momentum before the bell, premarket analysis becomes a foundational step in any trader's premarket routine.
In the Green - Premarket Gainers
On Monday, the following stocks are trading significantly higher in the premarket session.
1. Oscar Health Inc. (OSCR) - up 15% at $15.472. N2OFF Inc. (NITO) - up 9% at $2.843. Myomo Inc. (MYO) - up 9% at $0.834. Cullinan Therapeutics Inc. (CGEM) - up 8% at $10.235. Butterfly Network Inc. (BFLY) - up 7% at $2.846. Propanc Biopharma Inc. (PPCB) - up 7% at $0.877. Kairos Pharma Ltd. (KAPA) - up 7% at $0.718. Rezolute Inc. (RZLT) - up 6% at $10.409. Biogen Inc. (BIIB) - up 5% at $183.9410. Enliven Therapeutics Inc. (ELVN) - up 3% at $22.49
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.